New Conversation

MitchEdit channel

Would you like a receipt? http://planetsuzy.fun/ planetsuzy hd On the positive side, Namenda (memantine) for the treatment of moderate and severe Alzheimer's disease, reached $397.5 million, up 7.9%, while the antihypertensive Bystolic (nebivolol) jumped 16.8% to $126.0 million. Savella (milnacipran), a selective serotonin and norepinephrine dual reuptake inhibitor for fibromyalgia, brought in $25.0 million, down 6.0%.

Active Users

{{ guests }} {{ guests == 1 ? 'guest' : 'guests' }}
{{ each.name }}